Michael S Hearne Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Michael S Hearne.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Michael S Hearne. Michael S Hearne is Chief Financial Officer in LA JOLLA PHARMACEUTICAL CO ($LJPC) and Chief Financial Officer in Odonate Therapeutics, Inc. ($ODT).
Latest Insider Trading Transactions of Michael S Hearne
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 02 2021 | LJPC | LA JOLLA PHARMACEU ... | Hearne Michael S | Chief Financial Off ... | Option Exercise | A | 4.30 | 169 | 727 | 169 | |
Jun 02 2021 | LJPC | LA JOLLA PHARMACEU ... | Hearne Michael S | Chief Financial Off ... | Grant | A | 3.66 | 169 | 618 | 3,934 | 3.8 K to 3.9 K (+4.49 %) |
May 04 2021 | LJPC | LA JOLLA PHARMACEU ... | Hearne Michael S | Chief Financial Off ... | Option Exercise | A | 4.44 | 163 | 724 | 163 | |
May 04 2021 | LJPC | LA JOLLA PHARMACEU ... | Hearne Michael S | Chief Financial Off ... | Grant | A | 3.77 | 163 | 615 | 3,572 | 3.4 K to 3.6 K (+4.78 %) |
Apr 19 2021 | LJPC | LA JOLLA PHARMACEU ... | Hearne Michael S | Chief Financial Off ... | Option Exercise | A | 4.18 | 173 | 723 | 173 | |
Apr 19 2021 | LJPC | LA JOLLA PHARMACEU ... | Hearne Michael S | Chief Financial Off ... | Grant | A | 3.55 | 173 | 615 | 3,835 | 3.7 K to 3.8 K (+4.72 %) |
Apr 19 2021 | LJPC | LA JOLLA PHARMACEU ... | Hearne Michael S | Chief Financial Off ... | Option Exercise | A | 4.18 | 173 | 723 | 173 | |
Apr 19 2021 | LJPC | LA JOLLA PHARMACEU ... | Hearne Michael S | Chief Financial Off ... | Grant | A | 3.55 | 173 | 615 | 3,835 | 3.7 K to 3.8 K (+4.72 %) |
Apr 02 2021 | LJPC | LA JOLLA PHARMACEU ... | Hearne Michael S | Chief Financial Off ... | Option Exercise | A | 4.24 | 172 | 729 | 172 | |
Apr 02 2021 | LJPC | LA JOLLA PHARMACEU ... | Hearne Michael S | Chief Financial Off ... | Grant | A | 3.60 | 172 | 620 | 3,662 | 3.5 K to 3.7 K (+4.93 %) |
Mar 17 2021 | LJPC | LA JOLLA PHARMACEU ... | Hearne Michael S | Chief Financial Off ... | Option Exercise | A | 5.71 | 127 | 725 | 127 | |
Mar 17 2021 | LJPC | LA JOLLA PHARMACEU ... | Hearne Michael S | Chief Financial Off ... | Grant | A | 4.85 | 127 | 616 | 3,490 | 3.4 K to 3.5 K (+3.78 %) |
Mar 02 2021 | ODT | Odonate Therapeuti ... | Hearne Michael S | Chief Financial Off ... | Option Exercise | A | 21.05 | 34 | 716 | 34 | |
Mar 02 2021 | ODT | Odonate Therapeuti ... | Hearne Michael S | Chief Financial Off ... | Grant | A | 17.89 | 34 | 608 | 2,583 | 2.5 K to 2.6 K (+1.33 %) |
Feb 18 2021 | LJPC | LA JOLLA PHARMACEU ... | Hearne Michael S | Chief Financial Off ... | Option Exercise | A | 6.71 | 535 | 3,590 | 535 | |
Feb 18 2021 | LJPC | LA JOLLA PHARMACEU ... | Hearne Michael S | Chief Financial Off ... | Grant | A | 5.70 | 535 | 3,051 | 3,224 | 2.7 K to 3.2 K (+19.90 %) |
Feb 17 2021 | ODT | Odonate Therapeuti ... | Hearne Michael S | Chief Financial Off ... | Option Exercise | A | 24.93 | 28 | 698 | 28 | |
Feb 17 2021 | ODT | Odonate Therapeuti ... | Hearne Michael S | Chief Financial Off ... | Grant | A | 21.19 | 28 | 593 | 2,549 | 2.5 K to 2.5 K (+1.11 %) |
Feb 02 2021 | LJPC | LA JOLLA PHARMACEU ... | Hearne Michael S | Chief Financial Off ... | Option Exercise | A | 6.12 | 118 | 722 | 118 | |
Feb 02 2021 | LJPC | LA JOLLA PHARMACEU ... | Hearne Michael S | Chief Financial Off ... | Grant | A | 5.20 | 118 | 614 | 2,689 | 2.6 K to 2.7 K (+4.59 %) |
Feb 02 2021 | ODT | Odonate Therapeuti ... | Hearne Michael S | Chief Financial Off ... | Option Exercise | A | 23.11 | 31 | 716 | 31 | |
Feb 02 2021 | ODT | Odonate Therapeuti ... | Hearne Michael S | Chief Financial Off ... | Grant | A | 19.64 | 31 | 609 | 2,521 | 2.5 K to 2.5 K (+1.24 %) |
Jan 20 2021 | LJPC | LA JOLLA PHARMACEU ... | Hearne Michael S | Chief Financial Off ... | Option Exercise | A | 5.35 | 136 | 728 | 136 | |
Jan 20 2021 | LJPC | LA JOLLA PHARMACEU ... | Hearne Michael S | Chief Financial Off ... | Grant | A | 4.55 | 136 | 618 | 1,094 | 958 to 1.1 K (+14.20 %) |
Jan 20 2021 | ODT | Odonate Therapeuti ... | Hearne Michael S | Chief Financial Off ... | Option Exercise | A | 19.99 | 35 | 700 | 35 | |
Jan 20 2021 | ODT | Odonate Therapeuti ... | Hearne Michael S | Chief Financial Off ... | Grant | A | 16.99 | 35 | 595 | 2,490 | 2.5 K to 2.5 K (+1.43 %) |
Jan 05 2021 | LJPC | LA JOLLA PHARMACEU ... | Hearne Michael S | Chief Financial Off ... | Option Exercise | A | 3.88 | 171 | 663 | 171 | |
Jan 05 2021 | LJPC | LA JOLLA PHARMACEU ... | Hearne Michael S | Chief Financial Off ... | Grant | A | 3.30 | 171 | 564 | 958 | 787 to 958 (+21.73 %) |
Jan 05 2021 | LJPC | LA JOLLA PHARMACEU ... | Hearne Michael S | Chief Financial Off ... | Option Exercise | A | 3.88 | 171 | 663 | 171 | |
Jan 05 2021 | LJPC | LA JOLLA PHARMACEU ... | Hearne Michael S | Chief Financial Off ... | Grant | A | 3.30 | 171 | 564 | 958 | 787 to 958 (+21.73 %) |
Dec 17 2020 | ODT | Odonate Therapeuti ... | Hearne Michael S | Chief Financial Off ... | Option Exercise | A | 15.19 | 43 | 653 | 43 | |
Dec 17 2020 | ODT | Odonate Therapeuti ... | Hearne Michael S | Chief Financial Off ... | Grant | A | 12.91 | 43 | 555 | 2,105 | 2.1 K to 2.1 K (+2.09 %) |
Dec 16 2020 | LJPC | LA JOLLA PHARMACEU ... | Hearne Michael S | Chief Financial Off ... | Option Exercise | A | 4.50 | 147 | 662 | 147 | |
Dec 16 2020 | LJPC | LA JOLLA PHARMACEU ... | Hearne Michael S | Chief Financial Off ... | Grant | A | 3.83 | 147 | 562 | 787 | 640 to 787 (+22.97 %) |
Dec 14 2020 | LJPC | LA JOLLA PHARMACEU ... | Hearne Michael S | Chief Financial Off ... | Option Exercise | A | 4.53 | 52,191 | 236,425 | 52,191 | |
Dec 10 2020 | ODT | Odonate Therapeuti ... | Hearne Michael S | Chief Financial Off ... | Option Exercise | A | 16.52 | 22,639 | 373,996 | 22,639 | |
Dec 02 2020 | LJPC | LA JOLLA PHARMACEU ... | Hearne Michael S | Chief Financial Off ... | Option Exercise | A | 4.97 | 134 | 666 | 134 | |
Dec 02 2020 | LJPC | LA JOLLA PHARMACEU ... | Hearne Michael S | Chief Financial Off ... | Grant | A | 4.23 | 134 | 566 | 640 | 506 to 640 (+26.48 %) |
Dec 02 2020 | ODT | Odonate Therapeuti ... | Hearne Michael S | Chief Financial Off ... | Option Exercise | A | 15.02 | 45 | 676 | 45 | |
Dec 02 2020 | ODT | Odonate Therapeuti ... | Hearne Michael S | Chief Financial Off ... | Grant | A | 12.77 | 45 | 575 | 2,062 | 2 K to 2.1 K (+2.23 %) |
Nov 05 2020 | LJPC | LA JOLLA PHARMACEU ... | Hearne Michael S | Chief Financial Off ... | Option Exercise | A | 3.40 | 196 | 666 | 196 | |
Nov 05 2020 | LJPC | LA JOLLA PHARMACEU ... | Hearne Michael S | Chief Financial Off ... | Grant | A | 2.89 | 196 | 566 | 365 | 169 to 365 (+115.98 %) |
Nov 03 2020 | ODT | Odonate Therapeuti ... | Hearne Michael S | Chief Financial Off ... | Option Exercise | A | 14.41 | 46 | 663 | 46 | |
Nov 03 2020 | ODT | Odonate Therapeuti ... | Hearne Michael S | Chief Financial Off ... | Grant | A | 12.25 | 46 | 564 | 1,971 | 1.9 K to 2 K (+2.39 %) |
Oct 19 2020 | LJPC | LA JOLLA PHARMACEU ... | Hearne Michael S | Chief Financial Off ... | Option Exercise | A | 3.91 | 169 | 661 | 169 | |
Oct 19 2020 | LJPC | LA JOLLA PHARMACEU ... | Hearne Michael S | Chief Financial Off ... | Grant | A | 3.32 | 169 | 561 | 169 | 0 to 169 |
Oct 19 2020 | LJPC | LA JOLLA PHARMACEU ... | Hearne Michael S | Chief Financial Off ... | Option Exercise | A | 3.91 | 169 | 661 | 169 | |
Oct 19 2020 | LJPC | LA JOLLA PHARMACEU ... | Hearne Michael S | Chief Financial Off ... | Grant | A | 3.32 | 169 | 561 | 169 | 0 to 169 |
Oct 19 2020 | ODT | Odonate Therapeuti ... | Hearne Michael S | Chief Financial Off ... | Option Exercise | A | 15.70 | 42 | 659 | 42 | |
Oct 19 2020 | ODT | Odonate Therapeuti ... | Hearne Michael S | Chief Financial Off ... | Grant | A | 13.35 | 42 | 561 | 1,925 | 1.9 K to 1.9 K (+2.23 %) |
Oct 02 2020 | ODT | Odonate Therapeuti ... | Hearne Michael S | Chief Financial Off ... | Option Exercise | A | 13.43 | 50 | 672 | 50 | |
Oct 02 2020 | ODT | Odonate Therapeuti ... | Hearne Michael S | Chief Financial Off ... | Grant | A | 11.42 | 50 | 571 | 1,883 | 1.8 K to 1.9 K (+2.73 %) |
Sep 17 2020 | ODT | Odonate Therapeuti ... | Hearne Michael S | Chief Financial Off ... | Option Exercise | A | 15.37 | 43 | 661 | 43 | |
Sep 17 2020 | ODT | Odonate Therapeuti ... | Hearne Michael S | Chief Financial Off ... | Grant | A | 13.06 | 43 | 562 | 1,833 | 1.8 K to 1.8 K (+2.40 %) |
Aug 18 2020 | ODT | Odonate Therapeuti ... | Hearne Michael S | Chief Financial Off ... | Option Exercise | A | 36.13 | 18 | 650 | 18 | |
Aug 18 2020 | ODT | Odonate Therapeuti ... | Hearne Michael S | Chief Financial Off ... | Grant | A | 30.71 | 18 | 553 | 1,748 | 1.7 K to 1.7 K (+1.04 %) |
Aug 04 2020 | ODT | Odonate Therapeuti ... | Hearne Michael S | Chief Financial Off ... | Option Exercise | A | 36.37 | 18 | 655 | 18 | |
Aug 04 2020 | ODT | Odonate Therapeuti ... | Hearne Michael S | Chief Financial Off ... | Grant | A | 30.91 | 18 | 556 | 1,730 | 1.7 K to 1.7 K (+1.05 %) |
Jul 17 2020 | ODT | Odonate Therapeuti ... | Hearne Michael S | Chief Financial Off ... | Option Exercise | A | 41.17 | 17 | 700 | 17 | |
Jul 17 2020 | ODT | Odonate Therapeuti ... | Hearne Michael S | Chief Financial Off ... | Grant | A | 34.99 | 17 | 595 | 1,712 | 1.7 K to 1.7 K (+1.00 %) |
Jun 17 2020 | ODT | Odonate Therapeuti ... | Hearne Michael S | Chief Financial Off ... | Option Exercise | A | 40.25 | 17 | 684 | 17 | |
Jun 17 2020 | ODT | Odonate Therapeuti ... | Hearne Michael S | Chief Financial Off ... | Grant | A | 34.21 | 17 | 582 | 1,680 | 1.7 K to 1.7 K (+1.02 %) |
May 19 2020 | ODT | Odonate Therapeuti ... | Hearne Michael S | Chief Financial Off ... | Option Exercise | A | 28.24 | 47 | 1,327 | 47 | |
May 19 2020 | ODT | Odonate Therapeuti ... | Hearne Michael S | Chief Financial Off ... | Grant | A | 24.00 | 47 | 1,128 | 1,623 | 1.6 K to 1.6 K (+2.98 %) |
May 04 2020 | ODT | Odonate Therapeuti ... | Hearne Michael S | Chief Financial Off ... | Option Exercise | A | 28.15 | 47 | 1,323 | 47 | |
May 04 2020 | ODT | Odonate Therapeuti ... | Hearne Michael S | Chief Financial Off ... | Grant | A | 23.93 | 47 | 1,125 | 1,576 | 1.5 K to 1.6 K (+3.07 %) |
Apr 17 2020 | ODT | Odonate Therapeuti ... | Hearne Michael S | Chief Financial Off ... | Option Exercise | A | 26.85 | 50 | 1,343 | 50 | |
Apr 17 2020 | ODT | Odonate Therapeuti ... | Hearne Michael S | Chief Financial Off ... | Grant | A | 22.82 | 50 | 1,141 | 1,529 | 1.5 K to 1.5 K (+3.38 %) |
Apr 02 2020 | ODT | Odonate Therapeuti ... | Hearne Michael S | Chief Financial Off ... | Option Exercise | A | 27.61 | 24 | 663 | 24 | |
Apr 02 2020 | ODT | Odonate Therapeuti ... | Hearne Michael S | Chief Financial Off ... | Grant | A | 23.47 | 24 | 563 | 1,479 | 1.5 K to 1.5 K (+1.65 %) |
Mar 17 2020 | ODT | Odonate Therapeuti ... | Hearne Michael S | Chief Financial Off ... | Option Exercise | A | 23.05 | 29 | 668 | 29 | |
Mar 17 2020 | ODT | Odonate Therapeuti ... | Hearne Michael S | Chief Financial Off ... | Grant | A | 19.59 | 29 | 568 | 1,455 | 1.4 K to 1.5 K (+2.03 %) |
Feb 19 2020 | ODT | Odonate Therapeuti ... | Hearne Michael S | Chief Financial Off ... | Option Exercise | A | 31.45 | 21 | 660 | 21 | |
Feb 19 2020 | ODT | Odonate Therapeuti ... | Hearne Michael S | Chief Financial Off ... | Grant | A | 26.73 | 21 | 561 | 1,404 | 1.4 K to 1.4 K (+1.52 %) |
Feb 04 2020 | ODT | Odonate Therapeuti ... | Hearne Michael S | Chief Financial Off ... | Option Exercise | A | 29.20 | 23 | 672 | 23 | |
Feb 04 2020 | ODT | Odonate Therapeuti ... | Hearne Michael S | Chief Financial Off ... | Grant | A | 24.82 | 23 | 571 | 1,383 | 1.4 K to 1.4 K (+1.69 %) |
Feb 04 2020 | ODT | Odonate Therapeuti ... | Hearne Michael S | Chief Financial Off ... | Option Exercise | A | 29.20 | 23 | 672 | 23 | |
Feb 04 2020 | ODT | Odonate Therapeuti ... | Hearne Michael S | Chief Financial Off ... | Grant | A | 24.82 | 23 | 571 | 1,383 | 1.4 K to 1.4 K (+1.69 %) |
Jan 17 2020 | ODT | Odonate Therapeuti ... | Hearne Michael S | Chief Financial Off ... | Option Exercise | A | 27.23 | 24 | 654 | 24 | |
Jan 17 2020 | ODT | Odonate Therapeuti ... | Hearne Michael S | Chief Financial Off ... | Grant | A | 23.15 | 24 | 556 | 1,360 | 1.3 K to 1.4 K (+1.80 %) |
Jan 03 2020 | ODT | Odonate Therapeuti ... | Hearne Michael S | Chief Financial Off ... | Option Exercise | A | 32.45 | 20 | 649 | 20 | |
Jan 03 2020 | ODT | Odonate Therapeuti ... | Hearne Michael S | Chief Financial Off ... | Grant | A | 27.58 | 20 | 552 | 1,336 | 1.3 K to 1.3 K (+1.52 %) |
Dec 17 2019 | ODT | Odonate Therapeuti ... | Hearne Michael S | Chief Financial Off ... | Option Exercise | A | 28.97 | 22 | 637 | 22 | |
Dec 17 2019 | ODT | Odonate Therapeuti ... | Hearne Michael S | Chief Financial Off ... | Grant | A | 24.62 | 22 | 542 | 1,316 | 1.3 K to 1.3 K (+1.70 %) |
Dec 12 2019 | ODT | Odonate Therapeuti ... | Hearne Michael S | Chief Financial Off ... | Option Exercise | A | 30.51 | 32,173 | 981,598 | 32,173 | |
Dec 03 2019 | ODT | Odonate Therapeuti ... | Hearne Michael S | Chief Financial Off ... | Option Exercise | A | 34.38 | 19 | 653 | 19 | |
Dec 03 2019 | ODT | Odonate Therapeuti ... | Hearne Michael S | Chief Financial Off ... | Grant | A | 29.22 | 19 | 555 | 1,294 | 1.3 K to 1.3 K (+1.49 %) |
Nov 19 2019 | ODT | Odonate Therapeuti ... | Hearne Michael S | Chief Financial Off ... | Option Exercise | A | 33.10 | 19 | 629 | 19 | |
Nov 19 2019 | ODT | Odonate Therapeuti ... | Hearne Michael S | Chief Financial Off ... | Grant | A | 28.14 | 19 | 535 | 1,275 | 1.3 K to 1.3 K (+1.51 %) |
Nov 19 2019 | ODT | Odonate Therapeuti ... | Hearne Michael S | Chief Financial Off ... | Option Exercise | A | 33.10 | 19 | 629 | 19 | |
Nov 19 2019 | ODT | Odonate Therapeuti ... | Hearne Michael S | Chief Financial Off ... | Grant | A | 28.14 | 19 | 535 | 1,275 | 1.3 K to 1.3 K (+1.51 %) |
Oct 17 2019 | ODT | Odonate Therapeuti ... | Hearne Michael S | Chief Financial Off ... | Option Exercise | A | 28.50 | 22 | 627 | 22 | |
Oct 17 2019 | ODT | Odonate Therapeuti ... | Hearne Michael S | Chief Financial Off ... | Grant | A | 24.23 | 22 | 533 | 1,235 | 1.2 K to 1.2 K (+1.81 %) |
Oct 02 2019 | ODT | Odonate Therapeuti ... | Hearne Michael S | Chief Financial Off ... | Option Exercise | A | 26.03 | 25 | 651 | 25 | |
Oct 02 2019 | ODT | Odonate Therapeuti ... | Hearne Michael S | Chief Financial Off ... | Grant | A | 22.13 | 25 | 553 | 1,213 | 1.2 K to 1.2 K (+2.10 %) |
Oct 02 2019 | ODT | Odonate Therapeuti ... | Hearne Michael S | Chief Financial Off ... | Option Exercise | A | 26.03 | 25 | 651 | 25 | |
Oct 02 2019 | ODT | Odonate Therapeuti ... | Hearne Michael S | Chief Financial Off ... | Grant | A | 22.13 | 25 | 553 | 1,213 | 1.2 K to 1.2 K (+2.10 %) |
Sep 17 2019 | ODT | Odonate Therapeuti ... | Hearne Michael S | Chief Financial Off ... | Option Exercise | A | 28.36 | 23 | 652 | 23 | |
Sep 17 2019 | ODT | Odonate Therapeuti ... | Hearne Michael S | Chief Financial Off ... | Grant | A | 24.11 | 23 | 555 | 1,188 | 1.2 K to 1.2 K (+1.97 %) |
Sep 04 2019 | ODT | Odonate Therapeuti ... | Hearne Michael S | Chief Financial Off ... | Option Exercise | A | 30.81 | 21 | 647 | 21 | |
Sep 04 2019 | ODT | Odonate Therapeuti ... | Hearne Michael S | Chief Financial Off ... | Grant | A | 26.19 | 21 | 550 | 1,165 | 1.1 K to 1.2 K (+1.84 %) |
Aug 19 2019 | ODT | Odonate Therapeuti ... | Hearne Michael S | Chief Financial Off ... | Option Exercise | A | 33.44 | 19 | 635 | 19 | |
Aug 19 2019 | ODT | Odonate Therapeuti ... | Hearne Michael S | Chief Financial Off ... | Grant | A | 28.42 | 19 | 540 | 1,144 | 1.1 K to 1.1 K (+1.69 %) |
Aug 02 2019 | ODT | Odonate Therapeuti ... | Hearne Michael S | Chief Financial Off ... | Option Exercise | A | 40.75 | 16 | 652 | 16 | |
Aug 02 2019 | ODT | Odonate Therapeuti ... | Hearne Michael S | Chief Financial Off ... | Grant | A | 34.64 | 16 | 554 | 1,125 | 1.1 K to 1.1 K (+1.44 %) |
Jul 17 2019 | ODT | Odonate Therapeuti ... | Hearne Michael S | Chief Financial Off ... | Option Exercise | A | 35.17 | 18 | 633 | 18 | |
Jul 17 2019 | ODT | Odonate Therapeuti ... | Hearne Michael S | Chief Financial Off ... | Grant | A | 29.89 | 18 | 538 | 1,109 | 1.1 K to 1.1 K (+1.65 %) |
Jul 02 2019 | ODT | Odonate Therapeuti ... | Hearne Michael S | Chief Financial Off ... | Option Exercise | A | 36.69 | 17 | 624 | 17 | |
Jul 02 2019 | ODT | Odonate Therapeuti ... | Hearne Michael S | Chief Financial Off ... | Grant | A | 31.19 | 17 | 530 | 1,091 | 1.1 K to 1.1 K (+1.58 %) |
Jun 18 2019 | ODT | Odonate Therapeuti ... | Hearne Michael S | Chief Financial Off ... | Option Exercise | A | 25.00 | 26 | 650 | 26 | |
Jun 18 2019 | ODT | Odonate Therapeuti ... | Hearne Michael S | Chief Financial Off ... | Grant | A | 21.25 | 26 | 553 | 1,074 | 1 K to 1.1 K (+2.48 %) |
Jun 04 2019 | ODT | Odonate Therapeuti ... | Hearne Michael S | Chief Financial Off ... | Option Exercise | A | 21.49 | 30 | 645 | 30 | |
Jun 04 2019 | ODT | Odonate Therapeuti ... | Hearne Michael S | Chief Financial Off ... | Grant | A | 18.27 | 30 | 548 | 1,048 | 1 K to 1 K (+2.95 %) |
May 17 2019 | ODT | Odonate Therapeuti ... | Hearne Michael S | Chief Financial Off ... | Option Exercise | A | 22.20 | 29 | 644 | 29 | |
May 17 2019 | ODT | Odonate Therapeuti ... | Hearne Michael S | Chief Financial Off ... | Grant | A | 18.87 | 29 | 547 | 1,018 | 989 to 1 K (+2.93 %) |
May 02 2019 | ODT | Odonate Therapeuti ... | Hearne Michael S | Chief Financial Off ... | Option Exercise | A | 19.66 | 33 | 649 | 33 | |
May 02 2019 | ODT | Odonate Therapeuti ... | Hearne Michael S | Chief Financial Off ... | Grant | A | 16.71 | 33 | 551 | 989 | 956 to 989 (+3.45 %) |
Apr 17 2019 | ODT | Odonate Therapeuti ... | Hearne Michael S | Chief Financial Off ... | Option Exercise | A | 24.99 | 26 | 650 | 26 | |
Apr 17 2019 | ODT | Odonate Therapeuti ... | Hearne Michael S | Chief Financial Off ... | Grant | A | 21.24 | 26 | 552 | 956 | 930 to 956 (+2.80 %) |
Apr 02 2019 | ODT | Odonate Therapeuti ... | Hearne Michael S | Chief Financial Off ... | Option Exercise | A | 22.11 | 29 | 641 | 29 | |
Apr 02 2019 | ODT | Odonate Therapeuti ... | Hearne Michael S | Chief Financial Off ... | Grant | A | 18.79 | 29 | 545 | 930 | 901 to 930 (+3.22 %) |
Feb 20 2019 | ODT | Odonate Therapeuti ... | Hearne Michael S | Chief Financial Off ... | Option Exercise | A | 16.52 | 39 | 644 | 39 | |
Feb 20 2019 | ODT | Odonate Therapeuti ... | Hearne Michael S | Chief Financial Off ... | Grant | A | 14.04 | 39 | 548 | 835 | 796 to 835 (+4.90 %) |
Feb 04 2019 | ODT | Odonate Therapeuti ... | Hearne Michael S | Chief Financial Off ... | Option Exercise | A | 16.57 | 38 | 630 | 38 | |
Feb 04 2019 | ODT | Odonate Therapeuti ... | Hearne Michael S | Chief Financial Off ... | Option Exercise | A | 16.57 | 38 | 630 | 38 | |
Feb 04 2019 | ODT | Odonate Therapeuti ... | Hearne Michael S | Chief Financial Off ... | Grant | A | 14.08 | 38 | 535 | 796 | 758 to 796 (+5.01 %) |
Feb 04 2019 | ODT | Odonate Therapeuti ... | Hearne Michael S | Chief Financial Off ... | Grant | A | 14.08 | 38 | 535 | 796 | 758 to 796 (+5.01 %) |
Jan 17 2019 | ODT | Odonate Therapeuti ... | Hearne Michael S | Chief Financial Off ... | Option Exercise | A | 16.29 | 40 | 652 | 40 | |
Jan 17 2019 | ODT | Odonate Therapeuti ... | Hearne Michael S | Chief Financial Off ... | Grant | A | 13.85 | 40 | 554 | 758 | 718 to 758 (+5.57 %) |
Jan 03 2019 | ODT | Odonate Therapeuti ... | Hearne Michael S | Chief Financial Off ... | Option Exercise | A | 14.08 | 45,045 | 634,234 | 45,045 | |
Jan 03 2019 | ODT | Odonate Therapeuti ... | Hearne Michael S | Chief Financial Off ... | Grant | A | 11.97 | 45 | 539 | 718 | 673 to 718 (+6.69 %) |
Dec 18 2018 | ODT | Odonate Therapeuti ... | Hearne Michael S | Chief Financial Off ... | Option Exercise | A | 15.12 | 42 | 635 | 42 | |
Dec 18 2018 | ODT | Odonate Therapeuti ... | Hearne Michael S | Chief Financial Off ... | Grant | A | 12.85 | 42 | 540 | 673 | 631 to 673 (+6.66 %) |
Dec 04 2018 | ODT | Odonate Therapeuti ... | Hearne Michael S | Chief Financial Off ... | Option Exercise | A | 15.76 | 40 | 630 | 40 | |
Dec 04 2018 | ODT | Odonate Therapeuti ... | Hearne Michael S | Chief Financial Off ... | Grant | A | 13.40 | 40 | 536 | 631 | 591 to 631 (+6.77 %) |
Page: 1